Terms: = Gastric cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
204 results:
1. Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms.
Agostini A; Piro G; Inzani F; Quero G; Esposito A; Caggiano A; Priori L; Larghi A; Alfieri S; Casolino R; Scaglione G; Tondolo V; Cammarota G; Ianiro G; Corbo V; Biankin AV; Tortora G; Carbone C
Nat Commun; 2024 Mar; 15(1):2764. PubMed ID: 38553466
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA SNHG26 promotes gastric cancer progression and metastasis by inducing c-myc protein translation and an energy metabolism positive feedback loop.
Wu ZH; Wang YX; Song JJ; Zhao LQ; Zhai YJ; Liu YF; Guo WJ
Cell Death Dis; 2024 Mar; 15(3):236. PubMed ID: 38553452
[TBL] [Abstract] [Full Text] [Related]
3. A novel combined therapeutic strategy of Nano-EN-IR@Lip mediated photothermal therapy and stem cell inhibition for gastric cancer.
Yang L; Du YE; Liao F; Huang T; Liu Y; Liu J; Wang C; Zhan Z; Cao Y; Wang Z; Chen W
Biomed Pharmacother; 2024 May; 174():116486. PubMed ID: 38520865
[TBL] [Abstract] [Full Text] [Related]
4. Profiling Kinase Activities for Precision Oncology in Diffuse gastric cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract] [Full Text] [Related]
5. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
Weng J; Wu XF; Shao P; Liu XP; Wang CX
Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
[TBL] [Abstract] [Full Text] [Related]
6. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing myc.
Ding N; Cao G; Wang Z; Xu S; Chen W
Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
[TBL] [Abstract] [Full Text] [Related]
7. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
8. ZIC2 accelerates growth and stemness in gastric cancer through the Wnt/β-catenin pathway.
Yu Y; Tan C; Ding L; Zhu Z; Zhang G; Long C
Tissue Cell; 2023 Dec; 85():102222. PubMed ID: 37774522
[TBL] [Abstract] [Full Text] [Related]
9. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
10. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.
Yu M; Pan Q; Li W; Du T; Huang F; Wu H; He Y; Wu X; Shi H
Phytomedicine; 2023 Dec; 121():155045. PubMed ID: 37742526
[TBL] [Abstract] [Full Text] [Related]
11. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
[TBL] [Abstract] [Full Text] [Related]
12. The potential effect and mechanism of Saikosaponin A against gastric cancer.
Wang C; Zhang R; Chen X; Yuan M; Wu J; Sun Q; Miao C; Jing Y
BMC Complement Med Ther; 2023 Aug; 23(1):295. PubMed ID: 37608281
[TBL] [Abstract] [Full Text] [Related]
13. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate induced apoptosis by dissociation of c-FLIP/Ku70 complex in gastric cancer cells.
Shahriari Felordi M; Alikhani M; Farzaneh Z; Alipour Choshali M; Ebrahimi M; Aboulkheyr Es H; Piryaei A; Najimi M; Vosough M
J Cell Mol Med; 2023 Sep; 27(17):2572-2582. PubMed ID: 37537749
[TBL] [Abstract] [Full Text] [Related]
15. TRIM50 Inhibits gastric cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP.
Hu J; Huang R; Liang C; Wang Y; Wang M; Chen Y; Wu C; Zhang J; Liu Z; Zhao Q; Liu Z; Wang F; Yuan S
Mol Cancer Res; 2023 Oct; 21(10):1107-1119. PubMed ID: 37409971
[TBL] [Abstract] [Full Text] [Related]
16. Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric cancer.
Maron SB; Chatila W; Walch H; Chou JF; Ceglia N; Ptashkin R; Do RKG; Paroder V; Pandit-Taskar N; Lewis JS; Biachi De Castria T; Sabwa S; Socolow F; Feder L; Thomas J; Schulze I; Kim K; Elzein A; Bojilova V; Zatzman M; Bhanot U; Nagy RJ; Lee J; Simmons M; Segal M; Ku GY; Ilson DH; Capanu M; Hechtman JF; Merghoub T; Shah S; Schultz N; Solit DB; Janjigian YY
Clin Cancer Res; 2023 Sep; 29(18):3633-3640. PubMed ID: 37406106
[TBL] [Abstract] [Full Text] [Related]
17. MiR-455-3p inhibits gastric cancer progression by repressing Wnt/β-catenin signaling through binding to ARMC8.
Zhan T; Chen M; Liu W; Han Z; Zhu Q; Liu M; Tan J; Liu J; Chen X; Tian X; Huang X
BMC Med Genomics; 2023 Jul; 16(1):155. PubMed ID: 37400847
[TBL] [Abstract] [Full Text] [Related]
18. Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial.
Shitara K; Di Bartolomeo M; Mandala M; Ryu MH; Caglevic C; Olesinski T; Chung HC; Muro K; Goekkurt E; McDermott RS; Mansoor W; Wainberg ZA; Shih CS; Kobie J; Nebozhyn M; Cristescu R; Cao ZA; Loboda A; Özgüroğlu M
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37399357
[TBL] [Abstract] [Full Text] [Related]
19. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
20. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.
Fathi D; Elballal MS; Elesawy AE; Abulsoud AI; Elshafei A; Elsakka EGE; Ismail A; El-Mahdy HA; Elrebehy MA; Doghish AS
Life Sci; 2023 Jun; 322():121667. PubMed ID: 37023952
[TBL] [Abstract] [Full Text] [Related]
[Next]
